BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151 | -98.3% | 3 | -97.9% | 0.00% | -100.0% |
| Q2 2023 | $8,975 | +6548.1% | 142 | +4633.3% | 0.00% | – |
| Q1 2023 | $135 | -89.7% | 3 | -90.0% | 0.00% | – |
| Q4 2022 | $1,314 | +31.4% | 30 | +42.9% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 21 | -69.6% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 69 | +666.7% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
| Q4 2021 | $1,000 | -75.0% | 14 | -65.0% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | +300.0% | 40 | +344.4% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 9 | -64.0% | 0.00% | – |
| Q1 2021 | $2,000 | – | 25 | +525.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 4 | -99.6% | 0.00% | -100.0% |
| Q1 2020 | $56,000 | +600.0% | 969 | +822.9% | 0.01% | +800.0% |
| Q4 2019 | $8,000 | -69.2% | 105 | -70.8% | 0.00% | -75.0% |
| Q3 2019 | $26,000 | -21.2% | 359 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $33,000 | – | 359 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |